devices. The secondary end-point was to assess which device allowed easier training of application.
Study Design
In a prospective, single site, controlled, randomized pilot study, 12 intravascular (IV) therapy health care professionals (clinicians) were asked for their professional evaluations on two antimicrobial containing catheter dressings: 3M™ Tegaderm™ Chlorhexidine Gluconate (CHG) IV Securement Dressing (CHG gel dressing) and BIOPATCH ® Antimicrobial Dressing with Chlorhexidine Gluconate (CHG disk). The CHG gel dressing consists of a Tegaderm™ transparent adhesive dressing with an integrated, transparent, CHG gel pad. The CHG disk consists of an opaque disk impregnated with CHG on one side. The clinicians were asked to compare the ease of use, and performance factors featured in specific questions. The study was conducted using healthy volunteers in a testing facility.
This was a prospective, single site, controlled and randomized pilot study. The Institutional Review Board (IRB) from the testing facility, approved the study protocol and informed consent form, and ensured that the study was conducted in conformity with ethical principals of research. Subjects were given information regarding the study and were informed that data collected in the study may be used for publications. Their confidentialities would be protected and their names would not be revealed in any publications or other documents intended for public examination. Time was given to each subject to review the informed consent form. All subjectsʼ informed consents were obtained prior to any study procedures. The testing facility in which the study was conducted is not a covered entity; therefore subjectsʼ Health Insurance Portability and Accountability Act (HIPAA) authorizations were not obtained. Twelve subjects, who met the inclusion and exclusion criteria and were willing and able to consent, were enrolled from the testing facility. Subjects were compensated for their participation time in the study. Inclusion criteria for subjects were males or females 18 years of age or older.
Exclusion criteria for subjects included: 1. Subjects who had a sensitivity/allergy to adhesive products, such as medical tapes, or acrylates. 2. Subjects who had sensitivity to the antimicrobial agent CHG. 3. Subjects who had psoriasis, a history of dermatitis, or skin conditions that might be exacerbated by the action of removing adhesive materials. 4. Subjects who had active dermatitis (rash), sunburn, blemishes, broken skin or cuts, or skin infection on his or her neck and both upper arms. 5. Subjects who were pregnant or thought they might be pregnant or were nursing. 6. Subjects who had a history of diabetes.
Twelve clinicians (all were Registered Nurses; some had additional credentials such as BSN-CRNI-RN, CRNI-RN, and BSA-RN) were recruited from local health care facilities (acute care facilities, home health, outpatient infusion clinic.) They were health care professionals specializing in vascular access and infusion therapy and were experienced in applying and changing IV dressings in their practices. The clinicians were compensated for their time and commute to the testing facility. These clinicians had not used the CHG gel dressing in their practices, but some had experience using the CHG disks. The clinicians were informed of the study objectives and were shown a video of the applications of both devices before the study was conducted. The video of applications of the CHG gel dressing and CHG disk according to the manufacturersʼ instructions was recorded by a contract photographer at the testing facility. Application of the CHG gel dressing was demonstrated by a vascular access clinician (BSN, RN) from the testing facility. Application of the CHG disk was demonstrated by an IV infusion therapy health care professional (BSA, RN) recruited from a local hospital, who regularly used the device in her practice. After viewing the video, the clinicians were asked to apply and remove both catheter dressings according to the manufacturersʼ instructions. The clinicians were also provided with written instructions for use of each device before the conduct of the study.
Catheters were secured on the right and left sides of the subjectʼs neck to simulate the internal jugular (IJ) catheter placement using 3M™ Steri-Strip™. Catheters were also secured on the subjectʼs right and left arms around the vein area to simulate the Peripherally Inserted Central Catheter ( The order of application of the devices (CHG gel dressing or CHG disk) and the locations (subjectʼs right or left side) were randomized according to a computer generated balanced randomization schedule. For the CHG disk, the instructions call for securing the catheter and the disk to the skin with Bioclusive Study staff recorded the time it took to apply and remove the device and if the device was applied correctly. The clinician evaluated and compared the ease of use and performance of each device after completing the application and removal of both devices on each catheter site (PICC or IJ). The clinicians also completed a comparative questionnaire on the overall product performance of the two devices at the completion of the study. Three study staff members timed the cliniciansʼ application and removal of the products and assessed if the products were correctly applied. A trainer reviewed and trained the study staff on the timing procedure to minimize variability in the assessment.
The assessments of the following product performances were based on a five-point Likert type scale (1= much worse; 2= worse, 3= same as, 4 = better, 5 = much better).
• Overall performance of CHG gel dressing compared with CHG disk. • Ease of applying CHG gel dressing compared with CHG disk.
• Ease of applying CHG gel dressing correctly compared with CHG disk.
• Ease of removing CHG gel dressing compared with CHG disk.
• Ability to see the IV site through dressing or disk.
• Intuitive nature of applying CHG gel dressing compared with CHG disk.
• Ease of training another clinician to use CHG gel dressing compared with training them to use CHG disk.
The CHG gel and the CHG disk were also assessed for the following on a 1-5 scale (1=very easy to 5=very difficult) • Ease of applying the catheter dressing.
• Ease of applying the catheter dressing correctly.
• Ease of removal of the catheter dressing.
• Ease of training another clinician to use the device.
Data Analysis
The primary outcome variable was the comparative rating of ease of application of CHG gel dressing compared with that of the CHG disk. This evaluation was designed to detect a 1 point difference from a neutral score of 0, assuming a standard deviation of 1.1 points with 2 sided alpha=0.05 and 80% power. A sample of 12 clinicians was needed to detect this difference.
A one-sample t-test was conducted on the comparative rating scores. The scores were converted from a range of 1 to 5 to a range of -2 to +2 by subtracting 3 from each rating so that 0 is the neutral point. The times required to apply and remove the catheter dressings were analyzed using the paired t-test on the average across catheter sites and for each site separately. The ratings conducted separately on CHG gel dressing and CHG disk were compared using a paired t-test on the average ratings across catheter sites. In addition, each catheter site was analyzed separately. Fisherʼs exact test was used to test the difference in the percent of clinicians who applied the dressings correctly. Significance was assessed at p<0.05 (2-tailed) for all analyses.
Results
Twelve subjects were screened and enrolled in the study. Fourteen clinicians were contacted, and 12 were recruited into the study. A total of 24 CHG gel dressings and 24 CHG disks were applied on the simulated PICC and IJ sites. No complications or adverse events were reported during the conduct of the study.
After applying and removing both dressings, the clinicians made comparative assessments of the two dressings. The CHG gel dressing was rated significantly better in overall performance (p<0.0001) compared to the CHG disk. All 12 clinicians rated the CHG gel dressing better or much better. The CHG gel dressing was significantly easier to apply compared to the CHG disk (p<0.0001). The CHG gel dressing was also significantly better compared to the CHG disk in ease of correctly applying (p<0.0001), ease of removing (p=0.0002), ability to see the IV site (p<0.0001), ease of training another clinician to use (p<0.0001) and more intuitive to use (p<0.0001). Table 1 summarizes these results.
The time to apply the CHG gel dressing (mean = 70.7 seconds) was significantly shorter (p=0.0003) than the time to apply the CHG disk (mean = 87.3 seconds). The difference in application time was also statistically significant when IJ and PICC sites were analyzed separately (p=0.0008 and p=0.0028 respectively). The difference in removal time was not significantly different between the two products. Table 2 summarizes the time to apply and remove the dressings.
The clinicians also rated a number of factors after applying each dressing. Table 3 summarizes the results of these ratings. CHG gel dressing was rated significantly better than CHG disk for all variables except ease of removal. Ease of removal was not significantly different for PICCs or for PICC and IJ sites combined. For IJ sites, CHG gel dressing was significantly easier to remove than CHG disk (p=0.0261). On average it took 6.46 steps to apply CHG disk and 4.42 steps to apply CHG gel dressing (p<0.0001).
Clinicians applied the CHG gel dressing correctly in 91.7% of the IJ applications and 100% of the PICC applications (see Table  4 ). The clinicians applied the CHG disk dressings correctly in 83.3% of the IJ applications and 66.7% of the PICC applications. These differences were not statistically significant.
Discussion and Implications for Clinical Practice
The clinicians rated the CHG gel dressing to be statistically better than the CHG disk in the following attributes: overall performance, ease of application, ease of correctly applying, ease of removal, ability to see the IV insertion site, ease of training another clinician in dressing application, and more intuitive application. Twelve out of 12 clinicians rated CHG gel dressing to be statistically better in overall performance. The application of CHG gel dressing is more intuitive. It limits incorrect placement of the CHG gel pad and prevents it from being placed upside down. The application and removal of the CHG gel dressing is similar to that of the 3M™ Tegaderm™ Transparent Adhesive Dressing that is being used in standard practice. Therefore, minimal training is required for the CHG gel dressing. The CHG disk also requires a standard transparent dressing for securement of the disk and coverage of the catheter insertion site, thus increasing the number of steps to apply and using more staff time.
The components of the CHG gel dressing (the gel pad and the adhesive dressing) are transparent. This allows the health care professionals to visually monitor the catheter insertion sites on a regular basis as recommended in the Centers for Disease Control guidelines . Both CHG gel dressing and CHG disk contain CHG, a well known antiseptic agent with broad spectrum antibacterial and antifungal activity (Denton 2001; Larson, 1995) . Both dressings are designed to prevent colonization of skin flora around the catheter insertion site (OʼGrady, 2002; Mermel et al, 2001 ).
Limitations
The study was limited due to the fact that the catheters were secured on the insertion sites using Steri-Strips™ rather than sutures as in actual practice. The study could not account for the challenge or care encountered in placing and removing the catheter dressings to ensure the catheters were not moved in or out of the insertion sites; however, this limitation applied to both the CHG gel dressing and CHG disk applications. Another limitation was the fact that the clinicians were not blinded to the products used. Many of the performance assessments in this study were subjective in nature.
This was a controlled pilot study conducted on healthy volunteers. It excluded many variables that are typically encountered in clinical practice, such as dressing wear time and accumulation of blood and exudates under the dressings. Limitations in methods include the use of a 1 to 5 point scale in detecting a one point difference, on a subjective scale, as statistically significant. The clinical significance of this study needs to be validated in a clinical practice setting. 
